Albumin-bound paclitaxel, ABI-007 may show better efficacy than paclitaxel in basal-like breast cancers: Association between caveolin-1 expression and ABI-007

被引：17

作者：

Altundag, Kadri ^{[1
]}

Bulut, Nilufer ^{[1
]}

Dizdar, Omer ^{[1
]}

Harputluoglu, Hakan ^{[1
]}

机构：

[1] Univ Hacettepe, Inst Oncol, Dept Med Oncol, TR-06100 Ankara, Turkey

来源：

BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷 / 03期

关键词：

Breast Cancer; Paclitaxel; Docetaxel; Polysorbate; Hereditary Breast Cancer;

D O I：

10.1007/s10549-006-9250-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：329 / 330

页数：2

共 6 条

[1]

[Anonymous], 2003, TAX DOC INJ CONC PAC

[2]

*BRIST MYERS SQUIB, 2003, TAX PACL INJ PACK IN

[3] Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer [J].

Gradishar, WJ ;

Tjulandin, S ;

Davidson, N ;

Shaw, H ;

Desai, N ;

Bhar, P ;

Hawkins, M ;

O'Shaughnessy, J .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :7794-7803

[4]

PINILLA SM, 2006, BREAST CANC RES TREA

[5] Breast cancer molecular subtypes respond differently to preoperative chemotherapy [J].

Rouzier, R ;

Perou, CM ;

Symmans, WF ;

Ibrahim, N ;

Cristofanilli, M ;

Anderson, K ;

Hess, KR ;

Stec, J ;

Ayers, M ;

Wagner, P ;

Morandi, P ;

Fan, C ;

Rabiul, I ;

Ross, JS ;

Hortobagyi, GN ;

Pusztai, L .

CLINICAL CANCER RESEARCH, 2005, 11 (16) :5678-5685

[6]

Yao R., 2003, 26 ANN SAN ANT BREAS

← 1 →